Press Releases about Acorda Therapeutics![]()
Acorda Therapeutics Announces Delisting from Nasdaq
April 15, 2024
From Acorda Therapeutics
Via Business Wire
![]()
Acorda Therapeutics Announces Nasdaq Delisting Notification
April 03, 2024
From Acorda Therapeutics
Via Business Wire
![]() ![]() ![]() ![]() ![]()
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
November 13, 2023
From Acorda Therapeutics
Via Business Wire
![]() ![]() ![]() From Acorda Therapeutics
Via Business Wire
![]() ![]() ![]() From Acorda Therapeutics
Via Business Wire
![]() ![]() ![]() From Acorda Therapeutics
Via Business Wire
![]() ![]() From Acorda Therapeutics
Via Business Wire
![]() ![]() ![]() ![]() ![]() From Acorda Therapeutics
Via Business Wire
![]() ![]() ![]() ![]() ![]()
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement
February 14, 2023
From Acorda Therapeutics
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Acorda Therapeutics (NQ: ACOR )Press Releases about Acorda Therapeutics
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|